title: Effectiveness of mifepristone in combination with ethacridine lactate for second trimester pregnancy termination.
abstract: OBJECTIVE
  To compare the efficacy of mifepristone and ethacridine lactate with ethacridine lactate alone for second trimester pregnancy termination.
  
  
  METHODS
  Two hundred and seventy-six healthy women between 16 and 27 weeks of gestation, desiring a termination, were assigned at random into two groups. The study group consisted of 140 women who received an intra-amniotic injection of 100mg ethacridine lactate, followed by oral administration of 50mg mifepristone at 0, 12 and 24h (total dose of mifepristone 150mg). The control group consisted of 136 women who received an intra-amniotic injection of 100mg ethacridine lactate alone. The primary outcome measure was the induction-to-abortion interval. Secondary outcomes included blood loss in 24h, successful abortion rate, retained placental tissue rate, rate of uterine evacuation and cervical laceration.
  
  
  RESULTS
  Induction-to-abortion interval, blood loss in 24h, rate of retained placental tissue and uterine evacuation were significantly less in the study group compared with the control group (p<0.001). Termination was successful in 140 of 140 women (100%) in the study group and 133 of 136 women (97.8%) in the control group. All women in the study group delivered within 72h, and three nulliparous women in the control group did not deliver within 72h. The cervical laceration rate was 0 and 1.47% (2/136) in the study group and the control group, respectively. No significant difference in the successful abortion rate (p=0.235) or the cervical laceration rate (p=0.242) was found between the two groups.
  
  
  CONCLUSIONS
  Mifepristone in combination with ethacridine lactate may significantly improve the outcomes of second trimester pregnancy termination compared with ethacridine lactate alone, without increasing complications and side effects apart from nausea.
authors.affiliation: The Second People's Hospital of Yichang City, The Second People's Hospital of Three Gorges University, Yichang, China. Electronic address: 406632917@qq.com.
authors.forename: Quan
authors.initials: Q
authors.lastname: Mei
authors.affiliation: The Second People's Hospital of Yichang City, The Second People's Hospital of Three Gorges University, Yichang, China.
authors.forename: XiaoLan
authors.initials: X
authors.lastname: Li
authors.affiliation: The Second People's Hospital of Yichang City, The Second People's Hospital of Three Gorges University, Yichang, China.
authors.forename: HaiJuan
authors.initials: H
authors.lastname: Liu
authors.affiliation: The Second People's Hospital of Yichang City, The Second People's Hospital of Three Gorges University, Yichang, China.
authors.forename: HaiBo
authors.initials: H
authors.lastname: Zhou
mesh_terms: D000019:Abortifacient Agents / Q000008:administration & dosage*; D000028:Abortion, Induced; D000282:Administration, Intravaginal; D000284:Administration, Oral; D000328:Adult; D002681:China; D004975:Ethacridine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000008:administration & dosage*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second
chemical_list: D000019:Abortifacient Agents; D015735:Mifepristone; D004975:Ethacridine
keywords: Ethacridine lactate; Induction-to-abortion; Mifepristone; Second trimester pregnancy